Fact CheckerSign in

NCT07847177Completed

Nurse-Led Self-Management and Breathing Intervention in Type 2 Diabetes

Evaluation of Cardiovascular Insult Associated With Autonomic Dysfunction in Type 2 Diabetes Mellitus and the Effect of a Structured Nurse-Led Home-Based Intervention: A Two-Phase Analytical Study

Source: ClinicalTrials.gov · Last updated 30 Sept 2026

Brief summary (registry, in English)

Brief Summary This study evaluated the effect of a structured nurse-led home-based self-management and paced-breathing intervention on cardiovascular autonomic function and blood pressure among adults with type 2 diabetes mellitus. Participants with type 2 diabetes were randomly assigned in a 1:1 ratio to either an intervention group or a control group. The intervention included a structured home-based walking program, paced breathing at six breaths per minute, blood pressure and heart rate self-monitoring, lifestyle counseling, behavioral reinforcement, and weekly telephone follow-up by a nurse. Outcomes were assessed at baseline and at Weeks 4, 8, and 12.

Status (registry)
Completed
Study type
Interventional
Enrollment
80 (actual)
First submitted
23 Sept 2026
Start date
12 Nov 2023
Primary completion date
9 Apr 2024
Lead sponsor
Aziza Ibrahim Mohamed
NCT number
NCT07847177

What you commit to

  • Study type: Interventional
  • Participants enrolled: 80
  • From 12 Nov 2023 to the primary completion date, 9 Apr 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Current or previous smoking.
  • Use of medications known to substantially influence autonomic nervous system function.

Other illness

  • Ischemic heart disease.
  • Cardiac arrhythmias.
  • Chronic liver disease.
  • Chronic kidney disease.
  • Neurological disorders unrelated to diabetes.

Who the study is looking for

  • Male participants aged 35-55 years.
  • Documented diagnosis of type 2 diabetes mellitus for at least 1 year.
  • Receiving stable pharmacological treatment for at least 3 months before enrollment.
  • Clinically stable at the time of assessment.
  • Willing to participate and provide written informed consent.

Age in the registry: 35 years to 55 years · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Mansoura University Hospitals
Coordinator of this site? Confirm its status
Al MansurahEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.